Seer, Inc. Class A Common Stock (SEER) is a publicly traded Healthcare sector company. As of July 6, 2026, SEER trades at $2.29 with a market cap of $89.07M and a P/E ratio of 0.00. SEER moved +39.51% today. Year to date, SEER is -10.99%; over the trailing twelve months it is -26.70%. Its 52-week range spans $1.55 to $2.63. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces SEER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Seer Shares Jump 30% on Investor Update Highlighting Proteomics Pipeline: Seer’s shares surged 30% after it issued an investor update ahead of its annual meeting, reflecting investor optimism about the company’s strategic outlook. The update emphasized the development pipeline for its proteomics platform and management’s plans to advance commercial partnerships.
| Metric | Value |
|---|---|
| Price | $2.29 |
| Market Cap | $89.07M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.63 |
| 52-Week Low | $1.55 |
| Volume | 22.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $15.17M |
| Net Income | $-70.49M |
| Gross Margin | 48.70% |
2 analysts cover SEER: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.